Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parasitic Diseases

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    August 2019
  1. LIN JT, Parr JB, Ngasala B
    Non-falciparum malaria in Africa and learning from P. vivax in Asia.
    Clin Infect Dis. 2019 Aug 13. pii: 5549499. doi: 10.1093.
    PubMed     Text format    


  2. ACHAN J, Reuling I, Yap XZ, Dabira E, et al
    Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum controlled human infection.
    Clin Infect Dis. 2019 Aug 12. pii: 5546068. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2019
  3. BUI QUANG P, Huynh Hong Q, Tran Thanh D, Le Thanh D, et al
    Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017-2018).
    Clin Infect Dis. 2019 Jun 28. pii: 5525051. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. OKOMBO J, Fidock DA
    Pyronaridine-Artesunate Shows Promise as an Effective and Well-Tolerated Treatment for Artemisinin-Resistant Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Jun 28. pii: 5524934. doi: 10.1093.
    PubMed     Text format    


    March 2019
  5. ELKET N, Kendjo E, Thellier M, Assoumou L, et al
    Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France.
    Clin Infect Dis. 2019 Mar 15. pii: 5381062. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  6. AWANDU SS, Raman J, Bousema T, Birkholtz LM, et al
    Ultra-low-density Plasmodium falciparum infections in African settings.
    Clin Infect Dis. 2019 Feb 15. pii: 5320191. doi: 10.1093.
    PubMed     Text format    


  7. YEO TW, Weinberg JB, Lampah DA, Kenangalem E, et al
    Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Feb 12. pii: 5316441. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. BRADLEY J, Soumare HM, Mahamar A, Diawara H, et al
    Transmission-blocking effects of primaquine and methylene blue suggest P. falciparum gametocyte sterilisation rather than effects on sex ratio.
    Clin Infect Dis. 2019 Feb 12. pii: 5316265. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  9. ISLAM S
    AmBisome for Kala-azar and Post-Kala-Azar Dermal Leishmaniasis: An essential option but not a universal solution.
    Clin Infect Dis. 2018 Dec 18. pii: 5250912. doi: 10.1093/cid/ciy1033.
    PubMed     Text format    


  10. MOLLETT G, Bremer Hinckel BC, Bhattacharyya T, Marlais T, et al
    Detection of IgG1 against rK39 improves monitoring of treatment outcome in visceral leishmaniasis.
    Clin Infect Dis. 2018 Dec 12. pii: 5239677. doi: 10.1093/cid/ciy1062.
    PubMed     Text format     Abstract available


    November 2018
  11. MCCARTHY JS, Smith B, Reid M, Berman J, et al
    Blood schizonticidal activity and safety of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: A randomized, double-blinded, placebo-controlled Phase 1b study.
    Clin Infect Dis. 2018 Nov 1. pii: 5154907. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  12. MONDAL D, Bern C, Ghosh D, Rashid M, et al
    Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies.
    Clin Infect Dis. 2018 Oct 24. pii: 5144025. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  13. SOTO J, Soto P, Ajata A, Luque C, et al
    Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Clin Infect Dis. 2018 Sep 27. pii: 5107841. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. MODY RM, Lakhal-Naouar I, Sherwood JE, Koles NL, et al
    Asymptomatic Visceral Leishmania infantum Infection in U.S. Soldiers Deployed to Iraq.
    Clin Infect Dis. 2018 Sep 20. pii: 5103944. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. MBUI J, Olobo J, Omollo R, Solomos A, et al
    Pharmacokinetics, safety and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase-II clinical trial.
    Clin Infect Dis. 2018 Sep 5. pii: 5090844. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  16. LE RUTTE EA, Chapman LAC, Coffeng LE, Ruiz-Postigo JA, et al
    Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.
    Clin Infect Dis. 2018;66.
    PubMed     Text format     Abstract available


  17. TOOR J, Alsallaq R, Truscott JE, Turner HC, et al
    Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
    Clin Infect Dis. 2018;66.
    PubMed     Text format     Abstract available


    May 2018
  18. BUCHWALD AG, Sixpence A, Chimenya M, Damson M, et al
    Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi.
    Clin Infect Dis. 2018 May 16. pii: 4996917. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. TUIKUE NDAM N, Tornyigah B, Dossou AY, Escriou G, et al
    Persistent Plasmodium falciparum infection in women with an intent to become pregnant is a risk factor for pregnancy-associated malaria.
    Clin Infect Dis. 2018 May 4. pii: 4992589. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  20. DEN BOER M, Das AK, Akhter F, Burza S, et al
    Safety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladesh.
    Clin Infect Dis. 2018 Mar 15. pii: 4938630. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. GALATAS B, Marti-Soler H, Nhamussua L, Cistero P, et al
    Dynamics of afebrile Plasmodium falciparum Infections in Mozambican Men.
    Clin Infect Dis. 2018 Mar 13. pii: 4931589. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. PLEWES K, Kingston HWF, Ghose A, Wattanakul T, et al
    Acetaminophen as a Renoprotective Adjunctive Treatment in Patients with Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.
    Clin Infect Dis. 2018 Mar 12. pii: 4930781. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. TRIPURA R, Peto TJ, Nguon C, Davoeung C, et al
    A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multi Drug Resistant Falciparum Malaria in Cambodian Villages.
    Clin Infect Dis. 2018 Mar 7. pii: 4924016. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  24. VALMASEDA A, Macete E, Nhabomba A, Guinovart C, et al
    Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
    Clin Infect Dis. 2018;66:586-593.
    PubMed     Text format     Abstract available


    January 2018
  25. ROSSI G, Vernaeve L, Van den Bergh R, Nguon C, et al
    Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
    Clin Infect Dis. 2018 Jan 18. pii: 4816713. doi: 10.1093/cid/cix1064.
    PubMed     Text format     Abstract available


  26. TADESSE FG, Slater HC, Chali W, Teelen K, et al
    The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia.
    Clin Infect Dis. 2018 Jan 3. pii: 4786592. doi: 10.1093/cid/cix1123.
    PubMed     Text format     Abstract available


    December 2017
  27. MOMBO-NGOMA G, Remppis J, Sievers M, Zoleko Manego R, et al
    Efficacy and safety of fosmidomycin-piperaquine as non-artemisinin-based combination therapy for uncomplicated falciparum malaria - A single-arm, age-de-escalation proof of concept study in Gabon.
    Clin Infect Dis. 2017 Dec 26. pii: 4774674. doi: 10.1093/cid/cix1122.
    PubMed     Text format     Abstract available


    September 2017
  28. MOULIK S, Chaudhuri SJ, Sardar B, Ghosh M, et al
    Monitoring of parasite kinetics in Indian Post Kala Azar Dermal Leishmaniasis.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. DIRO E, Ritmeijer K, Boelaert M, Alves F, et al
    Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial Authors and affiliations.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. ROSSI G, Van den Bergh R, Nguon C, Debackere M, et al
    Adapting reactive case detection strategies for falciparum malaria in a low-transmission area in Cambodia.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  31. TOURE OA, Mwapasa V, Sagara I, Gaye O, et al
    Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, R
    Clin Infect Dis. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  33. ABONGOMERA C, Diro E, Vogt F, Tsoumanis A, et al
    The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  34. TINE RC, Sylla K, Faye BT, Poirot E, et al
    Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  35. MOLINA R, Ghosh D, Carrillo E, Monnerat S, et al
    Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
    Clin Infect Dis. 2017 May 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. WYSS K, Wangdahl A, Vesterlund M, Hammar U, et al
    Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. BJORKMAN A, Cook J, Sturrock H, Msellem M, et al
    Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.
    Clin Infect Dis. 2017;64:1236-1243.
    PubMed     Text format     Abstract available


    April 2017
  38. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. CHERNET A, Kling K, Sydow V, Kuenzli E, et al
    Accuracy of diagnostic tests for Schistosoma mansoni infection in asymptomatic Eritrean refugees: serology and POC-CCA against stool microscopy.
    Clin Infect Dis. 2017 Apr 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. IPPOLITO MM, Johnson J, Mullin C, Mallow C, et al
    The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  41. NEUMAYR A, Paris D, Genton B, Hatz C, et al
    Artemether-lumefantrine treatment failure in nonimmune European travelers with P. falciparum malaria: 5.3% now and 5.3% then - need to reconsider dosing in patients from non-endemic regions?
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format    


  42. PORTUGAL S, Tran TM, Ongoiba A, Bathily A, et al
    Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.
    Clin Infect Dis. 2017;64:645-653.
    PubMed     Text format     Abstract available


    February 2017
  43. WHITE NJ
    The Consequences of Treating Asymptomatic Malaria Parasitemia.
    Clin Infect Dis. 2017 Feb 8. doi: 10.1093.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: